H11.01
Amyloid pterygium
Clinical Classification Guidelines
Medical Intelligence & Overview
Amyloid pterygium is a rare eye condition characterized by the development of amyloid protein deposits in the pterygium, a benign growth of conjunctival tissue that extends onto the cornea. This condition can affect vision quality and eye health if left untreated, making awareness and proper diagnosis important for affected individuals.
Causes & Symptoms
Clinical Causes: Presence of abnormal amyloid protein deposits in the eye tissues Genetic predisposition in some cases Chronic irritation or inflammation of the eye Degenerative changes associated with aging Underlying systemic amyloidosis, which involves amyloid deposition in various organs
Key Symptoms: Mild to severe vision impairment Growth of a flesh-colored, translucent, or yellowish lesion on the conjunctiva Possible irritation, redness, or foreign body sensation in the eye Progressive enlarging of the pterygium onto the cornea Discomfort or tearing in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis of amyloid pterygium primarily involves a comprehensive eye examination, including slit-lamp microscopy to identify the characteristic lesions. In some cases, a biopsy of the affected tissue may be performed to confirm amyloid deposits under histopathological analysis. Advanced imaging techniques or laboratory tests may be used to assess systemic amyloidosis if suspected.
Treatment Protocols: Observation and regular monitoring for small or asymptomatic lesions Use of lubricating eye drops to reduce irritation Surgical removal of the pterygium if it causes significant vision impairment or cosmetic concerns Post-surgical care to prevent recurrence, which may involve topical medications Addressing underlying systemic conditions if systemic amyloidosis is identified
Clinical Advice & FAQs
Billing Guidance
Is H11.01 a billable ICD-10 code?
Yes, H11.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.01?
Clinical documentation must specify the nature of Amyloid pterygium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference